Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Neoplasms × olaparib × Clear all

Phase

Status

Recruiting 9 Completed 9 Unknown 3 Terminated 2 Withdrawn 1 Approved for marketing 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 5 Triple Negative Breast Neoplasms 2 Sarcoma 2 Prostatic Neoplasms 2 Breast Neoplasms 2 Uveal Melanoma 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Platinum-Refractory Fallopian Tube Carcinoma 1 Pancreatic Neoplasms 1 Neoplasms 1 Melanoma 1 Lymphoma 1 Liposarcoma 1 Fallopian Tube Neoplasms 1 Carcinoma, Squamous Cell 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Cisplatin 9 pembrolizumab 7 Radiosurgery 6 Gemcitabine 6 Paclitaxel 5 Dexamethasone 5 Taxes 4 Carboplatin 4 trametinib 3 ibrutinib 3 Surveys and Questionnaires 3 Standard of Care 3 Radiotherapy 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Lenalidomide 3 Fluorouracil 3 Erlotinib Hydrochloride 3 Blood Specimen Collection 3 Ascorbic Acid 3 venetoclax 2 veliparib 2 tocilizumab 2 pazopanib 2 obinutuzumab 2 naquotinib 2 lenvatinib 2 fludarabine 2 enzalutamide 2 Vemurafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06116578 2025-12-01

NeoSarc

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Withdrawn

Liposarcoma, Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡